Somatostatin receptor scintigraphy in pancreatic neuroendocrine tumor

#3344

Introduction: Pancreatic neuroendocrine tumors (PNET) are rare tumors, but their incidence is increasing. They are characterised by a high rate of metastasis (50%), mainly to the liver. Due to their relatively slow tumor growth, they are associated with prolonged survival rates. Somatostatin receptor scintigraphy (SRS) is a valuable tool for diagnostic, staging and follow-up.

Aim(s): SRS for exploration and staging of a metastatic PNET.

Materials and methods: We report the case of a 37-year-old man who presented two neuroendocrine tumors, one pulmonary operated and the other pancreatic, the CT scan revealed double tissue lesions at the pancreas, one at the head measuring 44 x 53mm and the other at the caudal portion measuring 19x19mm associated with several secondary nodules at the liver which the anatomopathological study was in favour of TNE moderately differented Grade 2.

Conference:

Presenting Author:

Authors: Borsali M, Ridouh M, Medjahdi A,

Keywords: pancreatic net, tektrotyd scan, metastasis,